1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
South and Central America Analysis Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ; Application ; Source, and Country

South and Central America Analysis Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ; Application ; Source, and Country

  • February 2021
  • 118 pages
  • ID: 6027866
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Jun 30th 2021


Table of Contents

Search Inside

The South and Central America organoids market is expected to reach US$ 98.85 million by 2027 from US$ 27.12 million in 2019. The market is expected to grow at a CAGR of 20.3% during 2020-2027. Increasing adoption of personalized drugs and drug discovery and growing focus on reducing animal use in researchare the major factors driving the market in the region. Additionally, increasing focus on COVID-19 research and drug discovery is likely to fuel the growth of the organoids market during the forecast period. However, thelack of skilled professionals is likely to restrain the growth of the market.
Organoids are self-organized three-dimensional tissue cultures derived from stem cells.These cultures are crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells.

Organoids grown from stem cells can divide indefinitely and produce various types of cells as part of their progeny. Organoids can range from less than the width of a hair to five millimeters.
Three-dimensional cultured organoids have become an important in vitro research tool that preserves genetic, phenotypic, and behavioral traits of in vivo organs.Biobanks of patient-derived organoids for many cancers and cystic fibrosis have a great value for drug development and personalized medicine.

Besides, organoids hold promise for regenerative medicine too.Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing.

As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA approved molecular entities in 2005; whereas, they accounted for more than 25%in 2016.Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines.

Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcome.
The coronavirus pandemic has become an enormous challenge in South and Central America region, as they are low-cost regions like developing regons.These regions are widely dependent on the import of pharmaceutical and biopharmaceutical products.

The lockdown situation in many countries has resulted in no trade in foreign countries.Thus, the Middle East and South and Central America countries have started producing API (active pharmaceutical ingredient) in their domestic market.

However, the cost of production was a challenge for several countries.Moreover, in Brazil studies have been conductedusing in vitro models such as stem cell-derived neural cells and cerebral organoids to prove thatSARS-CoV-2 caninfect brain cells.

SARS-CoV-2 has the ability to directly infect capillary organoids and kidney organoids, both established from human iPSCs. These observations explain the spread of the virus through the body and the loss of kidney function in severely ill individuals. Scientists are beginning to perform more experiments to explore how the COVID-19 virus replicates in the host or even test vaccines and drugs against COVID-19.
In terms of type, the intestine segment held the largest share of the organoids market in 2019.The kidney segment is expected to dominate the market during the forecast period. Chronic kidney disease is a major global health problem, as it affects 10% of the global population and kills millions of patients every year.This is expected to boost the growth of the kidney segment. The discovery of human induced pluripotent stem cells (hiPSCs) and the development of methods for the generation of 3D organoids, have opened the way for modeling human kidney development and disease in vitro, and testing new drugs directly on human tissue. Kidney organoids, derived from human pluripotent stem cells, have the potential to facilitate drug development.
Major secondary sources associated with the South and Central America organoids market report include World Health Organization, Brazilian Pharma Solutions, Food and Drug Administration, and National Center for Biotechnology Information.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2026

  • $ 4950
  • April 2021
  • 155 pages

The global stem cell therapy market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period. Growth in this market is majorly driven by ...

  • APAC
  • North America
  • Cell Therapy
  • Industry analysis
  • Health Expenditure
  • Musculoskeletal Disorders Prevalence


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on